Logotipo do repositório
 

Publicação:
Systematic review on the proteomic profile of Mycobacterium tuberculosis exposed to drugs

dc.contributor.authorZanetti Campanerut-Sa, Paula Aline
dc.contributor.authorGhiraldi-Lopes, Luciana Dias
dc.contributor.authorMeneguello, Jean Eduardo
dc.contributor.authorVieira Teixeira, Jorge Juarez
dc.contributor.authorLima Scodro, Regiane Bertin de
dc.contributor.authorDias Siqueira, Vera Lucia
dc.contributor.authorEstivalet Svidzinski, Terezinha Inez
dc.contributor.authorPavan, Fernando Rogerio [UNESP]
dc.contributor.authorCardoso, Rosilene Fressatti
dc.contributor.institutionUniversidade Estadual de Maringá (UEM)
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2018-11-26T17:44:23Z
dc.date.available2018-11-26T17:44:23Z
dc.date.issued2017-12-01
dc.description.abstractThe authors present an overview about proteomics studies in Mycobacterium tuberculosis exposed to some anti-tuberculosis drugs and new candidates, using two-dimensional gel electrophoresis and mass spectrometry. To date, that the authors have knowledge, this is the first studies that was performed specifically in M. tuberculosis using systematic review on electronic literature conducted in three databases using the following search terms: tuberculosis OR mycobacterium tuberculosis, proteome OR proteomics, and mass spectrometry electrospray ionization OR matrix-assisted laser desorption ionization OR two-dimensional gel electrophoresis. By electronic search, 622 abstracts of the original articles published from November 2003 to March 2016 were selected. After the selection, four articles fulfill proposed criteria and were included in this study. The studies reported changes in the protein profile of M. tuberculosis after exposure to isoniazid, ethambutol, streptomycin, ofloxacin, moxifloxacin and two new drugs candidates, SQ109 and ATB107. In conclusion, the proteins changes were related to the synthesis of mycolic acids, cellular metabolism pathways, bacterial stress and starvation.en
dc.description.affiliationUniv Estadual Maringa, Dept Clin Anal & Biomed, Ave Colombo,5790, BR-87020900 Maringa, Parana, Brazil
dc.description.affiliationState Univ Paulista Julio de Mesquita Filho, Dept Biol Sci, Fac Pharmaceut Sci Araraquara, Sao Paulo, Brazil
dc.description.affiliationUnespState Univ Paulista Julio de Mesquita Filho, Dept Biol Sci, Fac Pharmaceut Sci Araraquara, Sao Paulo, Brazil
dc.format.extent9
dc.identifierhttp://dx.doi.org/10.1002/prca.201600077
dc.identifier.citationProteomics Clinical Applications. Weinheim: Wiley-v C H Verlag Gmbh, v. 11, n. 11-12, 9 p., 2017.
dc.identifier.doi10.1002/prca.201600077
dc.identifier.issn1862-8346
dc.identifier.urihttp://hdl.handle.net/11449/163642
dc.identifier.wosWOS:000418253600001
dc.language.isoeng
dc.publisherWiley-Blackwell
dc.relation.ispartofProteomics Clinical Applications
dc.relation.ispartofsjr1,002
dc.rights.accessRightsAcesso restritopt
dc.sourceWeb of Science
dc.subjectAnti-tuberculosis drugs
dc.subjectMass spectrometry
dc.subjectProteome
dc.subjectTwo-dimensional electrophoresis
dc.subjectTuberculosis
dc.titleSystematic review on the proteomic profile of Mycobacterium tuberculosis exposed to drugsen
dc.typeResenhapt
dcterms.licensehttp://olabout.wiley.com/WileyCDA/Section/id-406071.html
dcterms.rightsHolderWiley-Blackwell
dspace.entity.typePublication
relation.isDepartmentOfPublication5004bcab-94af-4939-b980-091ae9d0a19e
relation.isDepartmentOfPublication.latestForDiscovery5004bcab-94af-4939-b980-091ae9d0a19e
unesp.departmentCiências Biológicas - FCFpt

Arquivos